Publication | Closed Access

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age

VaccinationVaccine SafetyVaccinologyVaccine DevelopmentAllergyMedicineImmunologyPrimary Vaccination CourseAvailable Hexavalent VaccinesPolyvalent VaccinePrecision VaccinologyVaccine Research